These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12679187)

  • 21. Role of thromboxane A2 in healing of gastric ulcers in rats.
    Takahashi S; Shigeta J; Ishikawa M; Kobayashi N; Okabe S
    Jpn J Pharmacol; 1999 Jan; 79(1):101-7. PubMed ID: 10082323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
    Yoshida T; Ichikawa Y; Tojo T; Homma M
    Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K; Ikata T; Tounai T
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney.
    Zoja C; Perico N; Corna D; Benigni A; Gabanelli M; Morigi M; Bertani T; Remuzzi G
    J Am Soc Nephrol; 1990 Nov; 1(5):799-807. PubMed ID: 2133429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats.
    Kuno Y; Iyoda M; Shibata T; Hirai Y; Akizawa T
    Br J Pharmacol; 2011 Mar; 162(6):1389-400. PubMed ID: 21133896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities of endothelium-dependent responses in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats are improved by chronic treatment with thromboxane A2 synthase inhibitor.
    Matsumoto T; Takaoka E; Ishida K; Nakayama N; Noguchi E; Kobayashi T; Kamata K
    Atherosclerosis; 2009 Jul; 205(1):87-95. PubMed ID: 19111834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T; Maeda K; Shibata M; Yamada K
    Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
    Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats.
    Ogawa M; Hirawa N; Tsuchida T; Eguchi N; Kawabata Y; Numabe A; Negoro H; Hakamada-Taguchi R; Seiki K; Umemura S; Urade Y; Uehara Y
    Nephrol Dial Transplant; 2006 Apr; 21(4):924-34. PubMed ID: 16384826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non-insulin-dependent diabetes mellitus.
    Uehara Y; Hirawa N; Kawabata Y; Numabe A; Gomi T; Ikeda T; Omata M
    Am J Hypertens; 1999 Jan; 12(1 Pt 1):21-7. PubMed ID: 10075380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboxane inhibition and monocrotaline-induced pulmonary hypertension in rats.
    Nagata T; Uehara Y; Hara K; Igarashi K; Hazama H; Hisada T; Kimura K; Goto A; Omata M
    Respirology; 1997 Dec; 2(4):283-9. PubMed ID: 9525298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats.
    Kikuchi Y; Imakiire T; Yamada M; Saigusa T; Hyodo T; Hyodo N; Suzuki S; Miura S
    Nephrol Dial Transplant; 2005 Aug; 20(8):1573-81. PubMed ID: 15905195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased thromboxane B2 excretion in diabetes mellitus.
    Katayama S; Inaba M; Maruno Y; Omoto A; Kawazu S; Ishii J
    J Lab Clin Med; 1987 Jun; 109(6):711-7. PubMed ID: 3585144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats.
    Li C; Yang CW; Park CW; Ahn HJ; Kim WY; Yoon KH; Suh SH; Lim SW; Cha JH; Kim YS; Kim J; Chang YS; Bang BK
    Kidney Int; 2003 Feb; 63(2):454-63. PubMed ID: 12631111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
    Lianos EA; Andres GA; Dunn MJ
    J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of thromboxane A2 activity during warm ischemia of the liver.
    Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K
    J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.